高い合格率

実に、我々のSEND 　Endocrinology and Diabetes (Specialty Certificate Examination)練習問題の通過率は98％～99％に達しています。一見すると、あなたは高質量に感銘を受けなければなりません。信じられないほど本当のことであるかを思うかもしれません。しかし、私たちの統計を見てみると、合格率についてのことを知り、あなたは以上の言ったことを信じられます。我々のSEND試験問題集は高い合格率の主な原因で人気を得ていることはよく知られています。一般的に言えば、難しい質問にEndocrinology and Diabetes (Specialty Certificate Examination)本当テスト問題のシンプルなレイアウトと詳細な解釈は高い合格率の達成を実現します。それは間違いなく我々のSEND　Endocrinology and Diabetes (Specialty Certificate Examination)試験参考書の質量を証明します。

Endocrinology and Diabetes (Specialty Certificate Examination)学習ガイドを使用する多くの利点

あなたのSEND　Endocrinology and Diabetes (Specialty Certificate Examination)練習問題を使用した後、想像以上に多くの利点があります。まず、あなたは自分の学ぶことを生かす大手会社の就職機会を得られます。次に、ごん存知のように、より大きな企業はそれらの中小企業よりも高い給料を持っています。それで、私たちのMRCPUK　SEND試験問題集を使用し、証明書を取得している限り、あなたは高い給与を持つことができます。また、高い給与は高いポジションを意味します。認定と高い給料を得ると、あなたはそれに伴って高い地位を享受することができます。

SEND試験問題集をすぐにダウンロード：成功に支払ってから、我々のシステムは自動的にメールであなたの購入した商品をあなたのメールアドレスにお送りいたします。（12時間以内で届かないなら、我々を連絡してください。Note：ゴミ箱の検査を忘れないでください。）

行き届いたサービス

SEND　Endocrinology and Diabetes (Specialty Certificate Examination)練習問題の編集プロセスと提供は、それ自身が一種のサービスであり、その中で態度と品質が最優先されます。お客様のニーズから考慮することから、あなたのようなより多くの成功した人々を引き付けるために、サービスが大きな違いを生むと言わなければなりません。一方では、我々のSEND試験問題集は全日24時間のオンラインお問い合わせを提供します。それで、あなたはどんな質問があっても、あなたはすぐに返事を得てどんな問題に困られません。その一方で、弊社の専門家はSEND　Endocrinology and Diabetes (Specialty Certificate Examination)学習指導資料の提供に重点にを置いて、毎日更新状態をチェックします。試験練習の更新があれば、すぐに顧客のメールボックスに送ります。顧客は次回のテストのために試験準備を早めることができます。私は私たちの専門家からの熱心なサービスとサポートによって、MRCPUK SEND試験に合格し、あなたのほしい認定を取得できます。

様々の学習資料から最高のSEND　Endocrinology and Diabetes (Specialty Certificate Examination)練習問題を選ぶのに疲れていますか？以前のてすとであなたのパフォーマンスについてあなたの両親からの絶えないおしゃべりに悩まされていますか？あなたは自分の学習状態を変更したいですか？もしそうなら、我々のSEND試験問題集ファイルを注意に払ってください。我々のSEND実際テスト問題は以下の方面からして最高の試験資料と考えられます。

MRCPUK SEND 試験シラバストピック:

MRCPUK Endocrinology and Diabetes (Specialty Certificate Examination) 認定 SEND 試験問題：

問題 #1

A 50-year-old woman with acromegaly presented with persistent sweating and headaches
despite having undergone trans-sphenoidal surgery and pituitary radiotherapy 2 years
previously. She had been intolerant of treatment with octreotide.
Investigations:
serum growth hormone11.1 ?g/L (<0.4)
serum insulin-like growth factor 186.2 nmol/L (5.6-23.3)
Following imaging, it was judged that there was no role for repeat surgery. She was treated
with pegvisomant 10 mg. Six months into treatment, her symptoms had improved.
Investigations (6 months later):
serum growth hormone20.3 ?g/L (<0.4)
serum insulin-like growth factor 115.2 nmol/L (5.6-23.3)
What is the most appropriate next step in management?

A. add cabergoline
B. increase dosage of pegvisomant
C. continue present dosage of pegvisomant
D. arrange another full course of pituitary radiotherapy
E. stop pegvisomant

問題 #2

A 77-year-old woman presented with a 10-week history of facial hirsutism, scalp hair loss and deepening of the voice.
On examination, her body mass index was 32 kg/m2 (18-25). Her blood pressure was 164/94 mmHg. She had coarse terminal hairs on her upper lip and beard areas. Abdominal examination was normal, but she refused examination of her external genitalia.
Investigations:
serum sodium144 mmol/L (137-144) serum potassium3.6 mmol/L (3.5-4.9) serum urea7.7 mmol/L (2.5-7.0) serum creatinine122 umol/L (60-110) fasting plasma glucose6.4 mmol/L (3.0-6.0) serum testosterone17.2 nmol/L (0.5-3.0) serum luteinising hormone2.2 U/L (>30.0)
What is the most appropriate initial investigation?

A. CT scan of abdomen and pelvis
B. overnight dexamethasone suppression test (after 1 mg dexamethasone)
C. serum dehydroepiandrosterone sulphate
D. plasma adrenocorticotropic hormone and serum cortisol
E. serum oestradiol

問題 #3

A 67-year-old woman with type 2 diabetes mellitus presented to the foot clinic with an ulcer at the plantar aspect of her fifth left toe. The ulcer probed to bone but there were no signs of inflammation. There had been a little improvement during 6 weeks of podiatric treatment, but there was some concern about possible osteomyelitis. An X-ray of toe 4 weeks previously had been normal.
What is the most appropriate next investigation?

A. white cell labelled scan
B. MR scan of foot
C. CT scan of foot
D. triple phase isotope bone scan
E. plain X-ray of foot

問題 #4

A 17-year-old girl was referred to the outpatient clinic with irritability, weight loss and difficulty sleeping. At the age of 4, she had presented with rapid growth, breast development and vaginal bleeding. The results of a gonadotropin-releasing hormone (GnRH) stimulation test performed at that time are given below.
serum oestradiolplasma FSHplasma LH
(200-400 pmol/L)(2.5-10.0 U/L)(2.5-10.0 U/L)
0 min365<0.7<0.5
30 min-<0.7<0.5
60 min-<0.7<0.5
She had been treated with GnRH analogue until the age of 11 and puberty had then progressed normally.
On examination, she was found to be tremulous, tachycardic and hyper-reflexic. Several large, irregular cafe-au-lait spots were found.
Investigations:
serum thyroid-stimulating hormone<0.05 mU/L (0.4-5.0)
serum free T436.0 pmol/L (10.0-22.0)
What is the most likely diagnosis?

A. Carney's complex
B. neurofibromatosis type 1
C. Cowden's syndrome
D. multiple endocrine neoplasia type 2
E. McCune-Albright syndrome

問題 #5

A 34-year-old woman with a 21-year history of type 1 diabetes mellitus had started treatment with subcutaneous insulin pump therapy 18 months previously. Her haemoglobin A1c before starting pump therapy was 77 mmol/mol (20-42) and she had experienced severe hypoglycaemic events without warning symptoms over the previous 4 years.
At review in clinic, she reported continuing episodes of severe hypoglycaemia without warning symptoms despite regular monitoring and advice from her insulin pump nurse specialist.
On examination, her blood pressure was 134/80 mmHg and fundoscopy revealed moderate background diabetic retinopathy. Examination of the feet revealed strong, palpable pedal pulses and early evidence of sensory neuropathy.
Investigations:
estimated glomerular filtration rate (MDRD)24 mL/min/1.73 m2 (>60)
haemoglobin A1c56 mmol/mol (20-42)
24-h urinary total protein2.3 g (<0.2)
What is the most appropriate next step in management?

A. refer for allogeneic pancreatic islet cell transplantation
B. refer for continuous glucose monitoring
C. refer for allogeneic pancreas transplantation
D. change to intensified subcutaneous insulin injections
E. refer for combined pancreas and kidney transplantation

解説：